Lowering Prescription Drug Prices for America’s Seniors and Families Act of 2020

Hozzl · 2022-02-08T23:23:00Z

Explore the details of Senate Bill 3384 Lowering Prescription Drug Prices for America’s Seniors and Families Act of 2020 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

2/8/2022, 11:23 PM

Congressional Summary of S 3384

Lowering Prescription Drug Prices for America's Seniors and Families Act of 2020

This bill makes a series of changes to requirements relating to prescription drug prices. Among other changes, the bill requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain covered drugs under the Medicare prescription drug benefit, allows individuals to import certain drugs from Canada to fill personal prescriptions, and establishes specific enforcement actions against patent infringement agreements that involve generic drug manufacturers and have anticompetitive effects.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 3384

Bill S 3384 is currently in the status of Bill Introduced since March 3, 2020. Bill S 3384 was introduced during Congress 116 and was introduced to the Senate on March 3, 2020. Bill S 3384's most recent activity was Read twice and referred to the Committee on Finance. as of March 3, 2020

Bipartisan Support of Bill S 3384

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 3384

Primary Policy Focus

Health

Potential Impact Areas

- Administrative law and regulatory procedures

- Administrative remedies

- Business ethics

- Canada

- Civil actions and liability

- Competition and antitrust

- Department of Health and Human Services

- Drug safety, medical device, and laboratory regulation

- Federal Trade Commission (FTC)

- Food and Drug Administration (FDA)

- Government information and archives

- Health care costs and insurance

- Health information and medical records

- Inflation and prices

- Intellectual property

- Licensing and registrations

- Manufacturing

- Medicare

- Prescription drugs

- Public participation and lobbying

- Trade restrictions

Alternate Title(s) of Bill S 3384

Lowering Prescription Drug Prices for America’s Seniors and Families Act of 2020

A bill to allow for negotiation of prices for certain covered Medicare part D drugs, to allow for importation by individuals of prescription drugs from Canada, to preserve access to affordable generics and biosimilars, to increase the use of real-time benefit tools to lower beneficiary costs, to establish a manufacturer discount program, and for other purposes.